New and revised FDA guidances for 2017

CDER’s plan for guidances for 2017

FDA plans to issue quite a number of new regulations in 2017 among most notably a new guidance on post marketing safety reporting and adaptive clinical trial design.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /